327 related articles for article (PubMed ID: 11566607)
21. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.
Spencer KS; Graus-Porta D; Leng J; Hynes NE; Klemke RL
J Cell Biol; 2000 Jan; 148(2):385-97. PubMed ID: 10648571
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine Kinase Receptors in Oncology.
Esteban-Villarrubia J; Soto-Castillo JJ; Pozas J; San Román-Gil M; Orejana-Martín I; Torres-Jiménez J; Carrato A; Alonso-Gordoa T; Molina-Cerrillo J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198314
[TBL] [Abstract][Full Text] [Related]
23. The developing role of receptors and adaptors.
Massie C; Mills IG
Nat Rev Cancer; 2006 May; 6(5):403-9. PubMed ID: 16612404
[TBL] [Abstract][Full Text] [Related]
24. Breakdown of endocytosis in the oncogenic activation of receptor tyrosine kinases.
Abella JV; Park M
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E973-84. PubMed ID: 19240253
[TBL] [Abstract][Full Text] [Related]
25. All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.
Margiotta A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198477
[TBL] [Abstract][Full Text] [Related]
26. Nuclear receptor tyrosine kinase transport and functions in cancer.
Chen MK; Hsu JL; Hung MC
Adv Cancer Res; 2020; 147():59-107. PubMed ID: 32593407
[TBL] [Abstract][Full Text] [Related]
27. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases.
Ostman A; Böhmer FD
Trends Cell Biol; 2001 Jun; 11(6):258-66. PubMed ID: 11356362
[TBL] [Abstract][Full Text] [Related]
28. Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors.
Peron M; Lovisa F; Poli E; Basso G; Bonvini P
PLoS One; 2015; 10(7):e0132330. PubMed ID: 26147305
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs: Non-coding fine tuners of receptor tyrosine kinase signalling in cancer.
Donzelli S; Cioce M; Muti P; Strano S; Yarden Y; Blandino G
Semin Cell Dev Biol; 2016 Feb; 50():133-42. PubMed ID: 26773212
[TBL] [Abstract][Full Text] [Related]
30. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling.
Denhardt DT
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):729-47. PubMed ID: 8836113
[TBL] [Abstract][Full Text] [Related]
31. Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment.
Ghosh S; Marrocco I; Yarden Y
Adv Cancer Res; 2020; 147():1-57. PubMed ID: 32593398
[TBL] [Abstract][Full Text] [Related]
32. Receptor tyrosine kinases: mechanisms of activation and signaling.
Hubbard SR; Miller WT
Curr Opin Cell Biol; 2007 Apr; 19(2):117-23. PubMed ID: 17306972
[TBL] [Abstract][Full Text] [Related]
33. Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.
Abou-Fayçal C; Hatat AS; Gazzeri S; Eymin B
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208660
[TBL] [Abstract][Full Text] [Related]
34. [Non-canonical Activation of Receptor Tyrosine Kinases in Cancer Progression].
Sakurai H
Yakugaku Zasshi; 2017; 137(2):141-144. PubMed ID: 28154322
[TBL] [Abstract][Full Text] [Related]
35. Insulin signalling: metabolic pathways and mechanisms for specificity.
Nystrom FH; Quon MJ
Cell Signal; 1999 Aug; 11(8):563-74. PubMed ID: 10433517
[TBL] [Abstract][Full Text] [Related]
36. GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation.
Delcourt N; Bockaert J; Marin P
Trends Pharmacol Sci; 2007 Dec; 28(12):602-7. PubMed ID: 18001849
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
Sun L; Tran N; Tang F; App H; Hirth P; McMahon G; Tang C
J Med Chem; 1998 Jul; 41(14):2588-603. PubMed ID: 9651163
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine kinase signalling in breast cancer.
Hynes NE
Breast Cancer Res; 2000; 2(3):154-7. PubMed ID: 11250704
[TBL] [Abstract][Full Text] [Related]
39. Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.
McDonell LM; Kernohan KD; Boycott KM; Sawyer SL
Hum Mol Genet; 2015 Oct; 24(R1):R60-6. PubMed ID: 26152202
[TBL] [Abstract][Full Text] [Related]
40. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents.
Knebel A; Rahmsdorf HJ; Ullrich A; Herrlich P
EMBO J; 1996 Oct; 15(19):5314-25. PubMed ID: 8895576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
